AbbVie Stays Flat as 6,000-Property AI Hunts Better Molecules

AbbVie NYSE:ABBV, the drugmaker behind major immunology, neuroscience and cancer medicines, added Iambic's AI platform to its small-molecule drug discovery work. Shares stays flat at around $265 at 11.34am ET time on Thursday.Iambic's Enchant v3 platform analyzes several types of biomedical data an…